BridgeBio Pharma, Inc. (BBIO): Price and Financial Metrics


BridgeBio Pharma, Inc. (BBIO)

Today's Latest Price: $26.67 USD

0.72 (-2.63%)

Updated Mar 27 12:00am

Add BBIO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

BBIO Daily Price Range
BBIO 52-Week Price Range

BBIO Stock Price Chart More Charts


BBIO Price/Volume Stats

Current price $26.67 52-week high $48.36
Prev. close $27.39 52-week low $14.23
Day low $25.71 Volume 1,016,700
Day high $27.86 Avg. volume 885,847
50-day MA $30.61 Dividend yield N/A
200-day MA $0.00 Market Cap 3.30B

BridgeBio Pharma, Inc. (BBIO) Company Bio


BridgeBio Pharma, Inc. engages in developing transformative medicines to treat patients who suffer from mendelian diseases. Its pipeline of 15 development programs includes product candidates from early discovery to late-stage development. The firm develops BBP-265, an oral small molecule transthyretin for the treatment of TTR amyloidosis, including cardiomyopathy and polyneuropathy manifestations; infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of FGFR-driven cancers and in preclinical development for the treatment of achondroplasia; and BBP-631, a preclinical adeno-associated virus, gene transfer product candidate, for the treatment of congenital adrenal hyperplasia caused by 21OHD. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly and Neil Kumar on May 17, 2019 and is headquartered in Palo Alto, CA.


BBIO Latest News Stream


Event/TimeNews Detail
Loading, please wait...

BBIO Latest Social Stream


Loading social stream, please wait...

View Full BBIO Social Stream

BBIO Price Returns

1-mo -16.34%
3-mo -24.75%
6-mo 27.61%
1-year N/A
3-year N/A
5-year N/A
YTD -23.91%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6893 seconds.